Anticoagulation Therapy Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Anticoagulation Therapy Market by Drug Type (Warfarin, Heparin, Novel Oral Anticoagulants, Others), By Route of Administration (Oral, Parenteral), By Application (Therapeutic applications, Laboratory Services), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Anticoagulation Therapy Market size is valued at USD 24,732.3 million in 2021 and is expected to grow at a CAGR of 7.8% from 2022 to 2028. The global market provides a detailed overview of the Anticoagulation Therapy market size, and that can be segmented by drug type, by route of administration, by application, and by Distribution channel. By drug type, the Anticoagulation Therapy market growth has been segmented into Warfarin, Heparin, Novel Oral Anticoagulants, and Others. The Novel oral anticoagulants (NOACs) segment is likely to be the largest and fastest-growing segment in terms of drug type. T Novel oral anticoagulants (NOACs) are a new type of anticoagulant drug. Furthermore, these are safe as a lower frequency of excessive bleeding is recorded, are suitable to use, have no reactions to food, and have a brief half-life. Some of the NOACs comprise dabigatran, apixaban, rivaroxaban, and edoxaban. These can be used in the stoppage and cure of atrial fibrillation or myocardial infarction, pulmonary embolism, and deep vein thrombosis (DVT).  Based on the Route of administration, the Anticoagulation Therapy market is segmented into Oral, Parenteral. Among these, the Oral route of administration segment is expected to have the fastest-growing market during the forecast period 2022-2028. Oral anticoagulants are expected to generate the highest market revenue during the forecast period. Oral anticoagulants are one of the most traditional and standard modes of administration of anticoagulant therapy, and they are expected to expand during the forecast period. The oral anticoagulants segment is further expected to grow as there are many prominent product launches. Due to technological advancements in anticoagulants and their influence on a considerable reduction in risk, this segment is further expected to increase the global anticoagulant market growth. Based on application, the Anticoagulation Therapy market is segmented into Therapeutic applications, Clinical Laboratory Services. Among these, the Therapeutic applications segment is expected to have the fastest-growing market during the forecast period 2022-2028. Based on the Distribution channel, the Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. The Hospital Pharmacies segment is expected to have a significant share in 2021.

Key Developments:

In June 2021, US FDA approved Pradaxa first oral anticoagulant to cure children aged 3 months to less than 12 years old with venous thromboembolism after they have obtained at least five days of treatment with a blood thinner given by injection

In February 2022, US FDA granted the fast track of Bayer’s oral Factor Xia inhibitor Asundexian

Anticoagulation Therapy Market

MARKET SUMMARY
-
7.8%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 7.8%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Anticoagulation Therapy Market

  • The anticoagulation therapy market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • The anticoagulation therapy market is segmented based on drug type, route of administration, application, distribution channel and geography.
Key Players
  • Bristol-Myers Squibb (U.S.)
  • Pfizer, Inc. (U.S.)
  • Johnson & Johnson Services Inc. (U.S.)
  • Alere, Inc. (U.S.)
  • Abbott, Inc. (U.S.)
Anticoagulation Therapy Market Drivers

The growing prevalence of arrhythmia, stroke, and blood vessel thromboembolism is anticipated to propel the market growth over the forecast years. Moreover, the increasing acceptance of NOACs and the growing number of outpatients are burgeoning the market growth over the forecast years.


North American Got Significant Share

Anticoagulation Therapy Market

North American market is expected to witness the highest market share during the forecast period

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2016-2021), and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Anticoagulation Therapy Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The anticoagulation therapy market is projected to expand at a CAGR of 7.8% during the forecast period

Bristol-Myers Squibb, Pfizer, Inc, Johnson & Johnson Services Inc, Alere, Inc., Abbott, Inc., F. Hoffmann La. Roche Ltd, Baxter International, Inc, Portola Pharmaceuticals, Inc., Daiichi Sankyo Company Ltd. , Siemens AG, CoaguSense, Inc.

North American is the fastest-growing region for anticoagulation therapy market


Report

Table Of Content

 

  1. Executive Summary
  2. Global Anticoagulation Therapy Market Introduction
    • Global Anticoagulation Therapy Market – Taxonomy
    • Global Anticoagulation Therapy Market –Definitions
      • Drug Type
      • Route of Administration
      • Application
      • Distribution Channel
  1. Global Anticoagulation Therapy Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Anticoagulation Therapy Market Dynamic Factors – Impact Analysis
    • Global Anticoagulation Therapy Market – Competition Landscape
    • Epidemiology
  2. Global Anticoagulation Therapy Market Analysis,2015 – 2019 and Forecast, 2020 – 2026
    • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market OpportunityAnalysis
  3. Global Anticoagulation Therapy Market, By Drug Type, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Warfarin
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Heparin
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Novel Oral Anticoagulants
      • Direct Factor Xa Inhibitors
        • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Direct Thrombin Inhibitors
        • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Antithrombin Protein Therapeutics
        • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Others
        • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
  1. Global Anticoagulation Therapy Market Forecast, By Route of Administration,2015 – 2019 and Forecast, 2017 – 2026
    • Oral
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Parenteral
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Anticoagulation Therapy Market Forecast, By Application, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Therapeutic applications
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Laboratory Services
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Anticoagulation Therapy Market Forecast, By Distribution Channel, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Hospital Pharmacies
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Retail Pharmacies
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Online Pharmacies
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Anticoagulation Therapy Market Forecast, By Region, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Anticoagulation Therapy Market – Opportunity Analysis Index, By Drug Type, By Route of Administration, By Application, By Distribution Channel and Region, 2020 – 2026
  2. North America Anticoagulation Therapy Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Drug Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Warfarin
      • Heparin
        • Novel Oral Anticoagulants
        • Direct Factor Xa Inhibitors
        • Direct Thrombin Inhibitors
        • Antithrombin Protein Therapeutics
      • Others
    • Route of Administration Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Therapeutic applications
      • Laboratory Services
    • Distribution Channel Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis 2016 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • US
      • Canada
    • North America Anticoagulation Therapy Market – Opportunity Analysis Index, By Drug Type, By Route of Administration, By Application, By Distribution Channel and Country, 2020 – 2026
    • North America Anticoagulation Therapy Market Dynamics – Trends
  3. Europe Anticoagulation Therapy Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Drug Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Warfarin
      • Heparin
        • Novel Oral Anticoagulants
        • Direct Factor Xa Inhibitors
        • Direct Thrombin Inhibitors
        • Antithrombin Protein Therapeutics
      • Others
    • Route of Administration Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Therapeutic applications
      • Laboratory Services
    • Distribution Channel Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Anticoagulation Therapy Market – Opportunity Analysis Index, By Drug Type, By Route of Administration, By Application, By Distribution Channel, and Country, 2020 – 2026
    • Europe Anticoagulation Therapy Market Dynamics – Trends
  4. Asia-Pacific Anticoagulation Therapy Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Drug Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Warfarin
      • Heparin
        • Novel Oral Anticoagulants
        • Direct Factor Xa Inhibitors
        • Direct Thrombin Inhibitors
        • Antithrombin Protein Therapeutics
      • Others
    • Route of Administration Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Therapeutic applications
      • Laboratory Services
    • Distribution Channel Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Anticoagulation Therapy Market – Opportunity Analysis Index, By Drug Class, By Route of Administration, By Application, By Distribution Channel, and Country, 2020 – 2026
    • Asia-Pacific Anticoagulation Therapy Market Dynamics – Trends
  5. Latin America Anticoagulation Therapy Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Drug Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Warfarin
      • Heparin
        • Novel Oral Anticoagulants
        • Direct Factor Xa Inhibitors
        • Direct Thrombin Inhibitors
        • Antithrombin Protein Therapeutics
      • Others
    • Route of Administration Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Therapeutic applications
      • Laboratory Services
    • Distribution Channel Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Anticoagulation Therapy Market – Opportunity Analysis Index, By Drug Class, By Route of Administration, By Application, By Distribution Channel, and Country, 2020 – 2026
    • Latin America Anticoagulation Therapy Market Dynamics – Trends
  6. Middle East and Africa Anticoagulation Therapy Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Drug Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Warfarin
      • Heparin
        • Novel Oral Anticoagulants
        • Direct Factor Xa Inhibitors
        • Direct Thrombin Inhibitors
        • Antithrombin Protein Therapeutics
      • Others
    • Route of Administration Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Therapeutic applications
      • Laboratory Services
    • Distribution Channel Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Anticoagulation Therapy Market – Opportunity Analysis Index, By Drug Class, By Route of Administration, By Application, By Distribution Channel, and Country,2020 – 2026
    • MEA Anticoagulation Therapy Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Drug Class& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Bristol-Myers Squibb (U.S.)
      • Pfizer, Inc. (U.S.)
      • Johnson & Johnson Services Inc. (U.S.)
      • Alere, Inc. (U.S.)
      • Abbott, Inc. (U.S.)
      • Hoffmann La. Roche Ltd. (Switzerland)
      • Baxter International, Inc. (U.S.)
      • Portola Pharmaceuticals, Inc. (U.S.)
      • Daiichi Sankyo Company Ltd. (Japan)
      • Siemens AG (Germany)
      • CoaguSense, Inc. (US)
  1. Research Methodology
  2. Key Assumptions and Acronyms
  1. Disclaimer
  2. The above mentioned segmentation is tentative; it is changed according to client’s requirement, or research feasibility.


Report

Company Profile

  • Bristol-Myers Squibb (U.S.)
  • Pfizer, Inc. (U.S.)
  • Johnson & Johnson Services Inc. (U.S.)
  • Alere, Inc. (U.S.)
  • Abbott, Inc. (U.S.)
  • F. Hoffmann La. Roche Ltd. (Switzerland)
  • Baxter International, Inc. (U.S.)
  • Portola Pharmaceuticals, Inc. (U.S.)
  • Daiichi Sankyo Company Ltd. (Japan)
  • Siemens AG (Germany)
  • CoaguSense, Inc. (US)

Description

Anticoagulation Therapy Market size is valued at USD 24,732.3 million in 2021 and is expected to grow at a CAGR of 7.8% from 2022 to 2028. The global market provides a detailed overview of the Anticoagulation Therapy market size, and that can be segmented by drug type, by route of administration, by application, and by Distribution channel. By drug type, the Anticoagulation Therapy market growth has been segmented into Warfarin, Heparin, Novel Oral Anticoagulants, and Others. The Novel oral anticoagulants (NOACs) segment is likely to be the largest and fastest-growing segment in terms of drug type. T Novel oral anticoagulants (NOACs) are a new type of anticoagulant drug. Furthermore, these are safe as a lower frequency of excessive bleeding is recorded, are suitable to use, have no reactions to food, and have a brief half-life. Some of the NOACs comprise dabigatran, apixaban, rivaroxaban, and edoxaban. These can be used in the stoppage and cure of atrial fibrillation or myocardial infarction, pulmonary embolism, and deep vein thrombosis (DVT).  Based on the Route of administration, the Anticoagulation Therapy market is segmented into Oral, Parenteral. Among these, the Oral route of administration segment is expected to have the fastest-growing market during the forecast period 2022-2028. Oral anticoagulants are expected to generate the highest market revenue during the forecast period. Oral anticoagulants are one of the most traditional and standard modes of administration of anticoagulant therapy, and they are expected to expand during the forecast period. The oral anticoagulants segment is further expected to grow as there are many prominent product launches. Due to technological advancements in anticoagulants and their influence on a considerable reduction in risk, this segment is further expected to increase the global anticoagulant market growth. Based on application, the Anticoagulation Therapy market is segmented into Therapeutic applications, Clinical Laboratory Services. Among these, the Therapeutic applications segment is expected to have the fastest-growing market during the forecast period 2022-2028. Based on the Distribution channel, the Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. The Hospital Pharmacies segment is expected to have a significant share in 2021.

Key Developments:

In June 2021, US FDA approved Pradaxa first oral anticoagulant to cure children aged 3 months to less than 12 years old with venous thromboembolism after they have obtained at least five days of treatment with a blood thinner given by injection

In February 2022, US FDA granted the fast track of Bayer’s oral Factor Xia inhibitor Asundexian

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX